102 related articles for article (PubMed ID: 23167426)
41. Correlations between serum levels of vascular endothelial growth factor and endostatin with clinical pathological characteristics of patients with gastrointestinal cancers.
Li M; Liu F; Sun P; Gao Y; Chen H; Liu H; Wang M; Chen J; Zhao Y
Hepatogastroenterology; 2012 Sep; 59(118):1865-8. PubMed ID: 22819906
[TBL] [Abstract][Full Text] [Related]
42. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
Bremnes RM; Camps C; Sirera R
Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
[TBL] [Abstract][Full Text] [Related]
43. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis.
Oda Y; Yamamoto H; Tamiya S; Matsuda S; Tanaka K; Yokoyama R; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2006 May; 19(5):738-45. PubMed ID: 16528367
[TBL] [Abstract][Full Text] [Related]
44. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G
Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776
[TBL] [Abstract][Full Text] [Related]
45. Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients.
Ferretti G; Fabi A; Carlini P; Papaldo P; Cordiali Fei P; Di Cosimo S; Salesi N; Giannarelli D; Alimonti A; Di Cocco B; D'Agosto G; Bordignon V; Trento E; Cognetti F
Oncology; 2005; 69(1):35-43. PubMed ID: 16088233
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast.
Shivakumar S; Prabhakar BT; Jayashree K; Rajan MG; Salimath BP
J Cancer Res Clin Oncol; 2009 Apr; 135(4):627-36. PubMed ID: 18936974
[TBL] [Abstract][Full Text] [Related]
47. Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin.
Kaya M; Wada T; Nagoya S; Yamashita T
J Orthop Sci; 2007 Nov; 12(6):562-7. PubMed ID: 18040639
[TBL] [Abstract][Full Text] [Related]
48. Postoperative progression of pulmonary metastasis in osteosarcoma.
Tsunemi T; Nagoya S; Kaya M; Kawaguchi S; Wada T; Yamashita T; Ishii S
Clin Orthop Relat Res; 2003 Feb; (407):159-66. PubMed ID: 12567143
[TBL] [Abstract][Full Text] [Related]
49. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
[TBL] [Abstract][Full Text] [Related]
50. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with pituitary adenomas.
Gruszka A; Kunert-Radek J; Pawlikowski M; Stepien H
Pituitary; 2005; 8(2):163-8. PubMed ID: 16379029
[TBL] [Abstract][Full Text] [Related]
51. Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable non-small cell lung cancer.
Hu Y; Hu MM; Shi GL; Han Y; Li BL
Eur J Surg Oncol; 2014 Sep; 40(9):1136-42. PubMed ID: 24998915
[TBL] [Abstract][Full Text] [Related]
52. Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in children with brain tumors.
Sobol-Milejska G; Mizia-Malarz A; Musiol K; Chudek J; Bożentowicz-Wikarek M; Wos H; Mandera M
Adv Clin Exp Med; 2017 Jul; 26(4):571-575. PubMed ID: 28691414
[TBL] [Abstract][Full Text] [Related]
53. [Assessment of angiogenesis in children' s osteosarcoma].
Sznurkowska K; Lenckowski R; Popadiuk S; Szumera M; Renke J; Korzon M
Med Wieku Rozwoj; 2006; 10(3 Pt 1):737-44. PubMed ID: 17317904
[TBL] [Abstract][Full Text] [Related]
54. Anti-angiogenic factor endostatin in osteosarcoma.
Kim HS; Lim SJ; Park YK
APMIS; 2009 Oct; 117(10):716-23. PubMed ID: 19775339
[TBL] [Abstract][Full Text] [Related]
55. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
Strohmeyer D; Strauss F; Rössing C; Roberts C; Kaufmann O; Bartsch G; Effert P
Anticancer Res; 2004; 24(3a):1797-804. PubMed ID: 15274358
[TBL] [Abstract][Full Text] [Related]
56. [Angiogenesis of brain after ischemia/reperfusion injury of brain in aged rats and changes in expressions of basic fibroblast growth factor and transformation growth factor-β1].
Li JS; Zhou YL; Liu K; Gao JF; Yang XK; Zhao YW; Liu ZG; Liu JX
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Oct; 22(10):583-6. PubMed ID: 20977838
[TBL] [Abstract][Full Text] [Related]
57. Angiogenic protein expression in advanced epithelial ovarian cancer.
Barton DP; Cai A; Wendt K; Young M; Gamero A; De Cesare S
Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846
[TBL] [Abstract][Full Text] [Related]
58. Endostatin variations in childhood acute lymphoblastic leukaemia--comparison with basic fibroblast growth factor and vascular endothelial growth factor.
Schneider P; Vasse M; Corbière C; Legrand E; Marie-Cardine A; Boquet C; Cazin L; Vannier JP
Leuk Res; 2007 May; 31(5):629-38. PubMed ID: 17011029
[TBL] [Abstract][Full Text] [Related]
59. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
60. Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease.
Takeshita S; Kawamura Y; Takabayashi H; Yoshida N; Nonoyama S
Clin Exp Immunol; 2005 Mar; 139(3):575-9. PubMed ID: 15730405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
